Modulation of chemokine activity by viruses

Current Opinion in Immunology

Volumn 22, Issue 4, 2010, Pages 482-487

  Alcami, Antonio ^a   Lira, Sergio A ^b  

^a CSIC   (Spain)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE BINDING PROTEIN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR1; CYCLOOXYGENASE 2; EVASIN 1; EVASIN 3; EVASIN 4; G PROTEIN COUPLED RECEPTOR; PROTEIN INHIBITOR; PROTEIN M3; THROMBOSPONDIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

CELL MIGRATION; DNA VIRUS; EQUINE HERPES VIRUS; HERPES VIRUS; HUMAN; IMMUNOMODULATION; MONKEYPOX VIRUS; NONHUMAN; POXVIRUS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TICK; VIRAL RESPIRATORY TRACT INFECTION; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS; VIRUS VIRULENCE;

ANIMALS; CHEMOKINES; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HUMANS; IMMUNITY, INNATE; POXVIRIDAE; POXVIRIDAE INFECTIONS;

EID: 77955654796     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2010.06.004     Document Type: Review

References (51)

1. Mackay C.R. Chemokines: immunology's high impact factors. Nat Immunol 2001, 2:95-101.
2. Zlotnik A., Yoshie O., Nomiyama H. The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol 2006, 7:243.
3. Handel T.M., Johnson Z., Crown S.E., Lau E.K., Proudfoot A.E. Regulation of protein function by glycosaminoglycans-as exemplified by chemokines. Annu Rev Biochem 2005, 74:385-410.
4. Proudfoot A.E. Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol 2002, 2:106-115.
5. Alcami A. Viral mimicry of cytokines, chemokines and their receptors. Nat Rev Immunol 2003, 3:36-50.
6. Grisotto M.G., Garin A., Martin A.P., Jensen K.K., Chan P., Sealfon S.C., Lira S.A. The human herpesvirus 8 chemokine receptor vGPCR triggers autonomous proliferation of endothelial cells. J Clin Invest 2006, 116:1264-1273.
7. Mutlu A.D., Cavallin L.E., Vincent L., Chiozzini C., Eroles P., Duran E.M., Asgari Z., Hooper A.T., La Perle K.M., Hilsher C., et al. In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. Cancer Cell 2007, 11:245-258.
8. Liu R., Li X., Tulpule A., Zhou Y., Scehnet J.S., Zhang S., Lee J.S., Chaudhary P.M., Jung J., Gill P.S. KSHV-induced notch components render endothelial and mural cell characteristics and cell survival. Blood 2010, 115:887-895.
9. Bakken T., He M., Cannon M.L. The phosphatase Shp2 is required for signaling by the Kaposi's sarcoma-associated herpesvirus viral GPCR in primary endothelial cells. Virology 2010, 397:379-388.
10. Emuss V., Lagos D., Pizzey A., Gratrix F., Henderson S.R., Boshoff C. KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia. PLoS Pathog 2009, 5:e1000616.
11. Sharma-Walia N., Paul A.G., Bottero V., Sadagopan S., Veettil M.V., Kerur N., Chandran B. Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion. PLoS Pathog 2010, 6:e1000777.
12. Shelby B.D., LaMarca H.L., McFerrin H.E., Nelson A.B., Lasky J.A., Sun G., Myatt L., Offermann M.K., Morris C.A., Sullivan D.E. Kaposi's sarcoma associated herpesvirus G-protein coupled receptor activation of cyclooxygenase-2 in vascular endothelial cells. Virol J 2007, 4:87.
13. Feng H., Dong X., Negaard A., Feng P. Kaposi's sarcoma-associated herpesvirus K7 induces viral G protein-coupled receptor degradation and reduces its tumorigenicity. PLoS Pathog 2008, 4:e1000157.
14. Maussang D., Verzijl D., van Walsum M., Leurs R., Holl J., Pleskoff O., Michel D., van Dongen G.A., Smit M.J. Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proc Natl Acad Sci U S A 2006, 103:13068-13073.
15. Maussang D., Langemeijer E., Fitzsimons C.P., Stigter-van Walsum M., Dijkman R., Borg M.K., Slinger E., Schreiber A., Michel D., Tensen C.P., et al. The human cytomegalovirus-encoded chemokine receptor US28 promotes angiogenesis and tumor formation via cyclooxygenase-2. Cancer Res 2009, 69:2861-2869.
16. Luttichau H.R. The herpesvirus 8 encoded chemokines vCCL2 (vMIP-II) and vCCL3 (vMIP-III) target the human but not the murine lymphotactin receptor. Virol J 2008, 5:50.
17. Choi Y.B., Nicholas J. Autocrine and paracrine promotion of cell survival and virus replication by human herpesvirus 8 chemokines. J Virol 2008, 82:6501-6513.
18. Luttichau H.R. The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist. J Biol Chem 2010, 285:9137-9146.
19. Alcami A., Saraiva M. Chemokine binding proteins encoded by pathogens. Adv Exp Med Biol 2009, 666:167-179.
20. Alexander J.M., Nelson C.A., van Berkel V., Lau E.K., Studts J.M., Brett T.J., Speck S.H., Handel T.M., Virgin H.W., Fremont D.H. Structural basis of chemokine sequestration by a herpesvirus decoy receptor. Cell 2002, 111:343-356.
21. Alexander-Brett J.M., Fremont D.H. Dual GPCR and GAG mimicry by the M3 chemokine decoy receptor. J Exp Med 2007, 204:3157-3172.
22. Webb L.M., Smith V.P., Alcami A. The gammaherpesvirus chemokine binding protein can inhibit the interaction of chemokines with glycosaminoglycans. FASEB J 2004, 18:571-573.
23. Bryant N.A., Davis-Poynter N., Vanderplasschen A., Alcami A. Glycoprotein G isoforms from some alphaherpesviruses function as broad-spectrum chemokine binding proteins. EMBO J 2003, 22:833-846.
24. Ng A., Tscharke D.C., Reading P.C., Smith G.L. The vaccinia virus A41L protein is a soluble 30kDa glycoprotein that affects virus virulence. J Gen Virol 2001, 82:2095-2105.
25. Clark R.H., Kenyon J.C., Bartlett N.W., Tscharke D.C., Smith G.L. Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy. J Gen Virol 2006, 87:29-38.
26. Bahar M.W., Kenyon J.C., Putz M.M., Abrescia N.G., Pease J.E., Wise E.L., Stuart D.I., Smith G.L., Grimes J.M. Structure and function of A41, a vaccinia virus chemokine binding protein. PLoS Pathog 2008, 4:e5.
27. Ruiz-Arguello M.B., Smith V.P., Campanella G.S., Baleux F., Arenzana-Seisdedos F., Luster A.D., Alcami A. An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain. J Virol 2008, 82:917-926.
28. Johnson Z., Proudfoot A.E., Handel T.M. Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention. Cytokine Growth Factor Rev 2005, 16:625-636.
29. Carfi A., Smith C.A., Smolak P.J., McGrew J., Wiley D.C. Structure of a soluble secreted chemokine inhibitor vCCI (p35) from cowpox virus. Proc Natl Acad Sci U S A 1999, 96:12379-12383.
30. Arnold P.L., Fremont D.H. Structural determinants of chemokine binding by an Ectromelia virus-encoded decoy receptor. J Virol 2006, 80:7439-7449.
31. Van de Walle G.R., Kaufer B.B., Chbab N., Osterrieder N. Analysis of the herpesvirus chemokine-binding glycoprotein G residues essential for chemokine binding and biological activity. J Biol Chem 2009, 284:5968-5976.
32. Viejo-Borbolla A., Munoz A., Tabares E., Alcami A. Glycoprotein G from pseudorabies virus binds to chemokines with high affinity and inhibits their function. J Gen Virol 2010, 91:23-31.
33. Devlin J.M., Viejo-Borbolla A., Browning G.F., Noormohammadi A.H., Gilkerson J.R., Alcami A., Hartley C.A. Evaluation of immunological responses to a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus. Vaccine 2010, 28:1325-1332.
34. Van de Walle G.R., May M.L., Sukhumavasi W., von Einem J., Osterrieder N. Herpesvirus chemokine-binding glycoprotein G (gG) efficiently inhibits neutrophil chemotaxis in vitro and in vivo. J Immunol 2007, 179:4161-4169.
35. Van de Walle G.R., Sakamoto K., Osterrieder N. CCL3 and viral chemokine-binding protein gg modulate pulmonary inflammation and virus replication during equine herpesvirus 1 infection. J Virol 2008, 82:1714-1722.
36. Lateef Z., Baird M.A., Wise L.M., Mercer A.A., Fleming S.B. Orf virus-encoded chemokine-binding protein is a potent inhibitor of inflammatory monocyte recruitment in a mouse skin model. J Gen Virol 2009, 90:1477-1482.
37. Lateef Z., Baird M.A., Wise L.M., Young S., Mercer A.A., Fleming S.B. The chemokine-binding protein encoded by the poxvirus orf virus inhibits recruitment of dendritic cells to sites of skin inflammation and migration to peripheral lymph nodes. Cell Microbiol 2010, 12:665-676.
38. Jones J.M., Messauodi I., Estep R.D., Orzechowska B., Wong S.W. Monkeypox virus viral chemokine inhibitor (MPV vCCI), a potent inhibitor of rhesus macrophage inflammatory protein-1. Cytokine 2008, 43:220-228.
39. Lira S.A., Viejo-Borbolla A., Shang L., Martin A.P. The chemokine-binding protein M3 as a tool to understand the chemokine network in vivo. Methods Enzymol 2009, 460:193-207.
40. Jensen K.K., Chen S.C., Hipkin R.W., Wiekowski M.T., Schwarz M.A., Chou C.C., Simas J.P., Alcami A., Lira S.A. Disruption of CCL21-induced chemotaxis in vitro and in vivo by M3, a chemokine-binding protein encoded by murine gammaherpesvirus 68. J Virol 2003, 77:624-630.
41. Martin A.P., Canasto-Chibuque C., Shang L., Rollins B.J., Lira S.A. The chemokine decoy receptor M3 blocks CC chemokine ligand 2 and CXC chemokine ligand 13 function in vivo. J Immunol 2006, 177:7296-7302.
42. Pyo R., Jensen K.K., Wiekowski M.T., Manfra D., Alcami A., Taubman M.B., Lira S.A. Inhibition of intimal hyperplasia in transgenic mice conditionally expressing the chemokine-binding protein M3. Am J Pathol 2004, 164:2289-2297.
43. Martin A.P., Alexander-Brett J.M., Canasto-Chibuque C., Garin A., Bromberg J.S., Fremont D.H., Lira S.A. The chemokine binding protein M3 prevents diabetes induced by multiple low doses of streptozotocin. J Immunol 2007, 178:4623-4631.
44. Martin A.P., Grisotto M.G., Canasto-Chibuque C., Kunkel S.L., Bromberg J.S., Furtado G.C., Lira S.A. Islet expression of M3 uncovers a key role for chemokines in the development and recruitment of diabetogenic cells in NOD mice. Diabetes 2008, 57:387-394.
45. Shang L., Thirunarayanan N., Viejo-Borbolla A., Martin A.P., Bogunovic M., Marchesi F., Unkeless J.C., Ho Y., Furtado G.C., Alcami A., et al. Expression of the chemokine binding protein M3 promotes marked changes in the accumulation of specific leukocytes subsets within the intestine. Gastroenterology 2009, 137:1006-1018.
46. Frauenschuh A., Power C.A., Deruaz M., Ferreira B.R., Silva J.S., Teixeira M.M., Dias J.M., Martin T., Wells T.N., Proudfoot A.E. Molecular cloning and characterization of a highly selective chemokine-binding protein from the tick Rhipicephalus sanguineus. J Biol Chem 2007, 282:27250-27258.
47. Deruaz M., Frauenschuh A., Alessandri A.L., Dias J.M., Coelho F.M., Russo R.C., Ferreira B.R., Graham G.J., Shaw J.P., Wells T.N., et al. Ticks produce highly selective chemokine binding proteins with antiinflammatory activity. J Exp Med 2008, 205:2019-2031.
48. Smith P., Fallon R.E., Mangan N.E., Walsh C.M., Saraiva M., Sayers J.R., McKenzie A.N., Alcami A., Fallon P.G. Schistosoma mansoni secretes a chemokine binding protein with antiinflammatory activity. J Exp Med 2005, 202:1319-1325.
49. Dias J.M., Losberger C., Deruaz M., Power C.A., Proudfoot A.E., Shaw J.P. Structural basis of chemokine sequestration by a tick chemokine binding protein: the crystal structure of the complex between Evasin-1 and CCL3. PLoS One 2009, 4:e8514.
50. Vieira A.T., Fagundes C.T., Alessandri A.L., Castor M.G., Guabiraba R., Borges V.O., Silveira K.D., Vieira E.L., Goncalves J.L., Silva T.A., et al. Treatment with a novel chemokine-binding protein or eosinophil lineage-ablation protects mice from experimental colitis. Am J Pathol 2009, 175:2382-2391.
51. Castor M.G., Rezende B., Resende C.B., Alessandri A.L., Fagundes C.T., Sousa L.P., Arantes R.M., Souza D.G., Silva T.A., Proudfoot A.E., et al. The CCL3/macrophage inflammatory protein-1alpha-binding protein evasin-1 protects from graft-versus-host disease but does not modify graft-versus-leukemia in mice. J Immunol 2010, 184:2646-2654.